Ferroglobe Files Annual Report on Form 20-F with the SEC
LONDON, June 01, 2020 (GLOBE NEWSWIRE) — Ferroglobe PLC (NASDAQ:GSM), (“Ferroglobe”, “the Company”, “we” or “our”), a global, leading producer of […]
SurveyMonkey Helps Organizations Reimagine Return to Work
SAN MATEO, Calif., June 01, 2020 (GLOBE NEWSWIRE) — SurveyMonkey (Nasdaq: SVMK) today announced its latest return to work offering […]
Iterum Therapeutics Announces Topline Results for a Phase 3 Clinical Trial of Oral and IV Sulopenem in Complicated Urinary Tract Infection
DUBLIN, Ireland and CHICAGO, June 01, 2020 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM), a clinical-stage pharmaceutical company focused […]
SurveyMonkey Helps Organisations Reimagine Return to Work
LONDON, June 01, 2020 (GLOBE NEWSWIRE) — SurveyMonkey (Nasdaq: SVMK) today announced its latest return to work offering for enterprise […]
ARCA Biopharma Announces $9.4 Million Registered Direct Offering
WESTMINSTER, Colo., June 01, 2020 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO) a late stage biopharmaceutical company applying a […]
Spero Therapeutics to Present at the Jefferies 2020 Virtual Healthcare Conference
CAMBRIDGE, Mass., June 01, 2020 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, […]
TRACON Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
SAN DIEGO, June 01, 2020 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company focused on the […]
Catalyst Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
CORAL GABLES, Fla., June 01, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused […]
Ayala Pharmaceuticals to Present at Upcoming Investor Conferences
REHOVOT, Israel and WILMINGTON, Del., June 01, 2020 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company […]
Neoleukin Therapeutics Announces Appointment of Erin Lavelle to Board of Directors
SEATTLE, June 01, 2020 (GLOBE NEWSWIRE) — Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to […]
